744 related articles for article (PubMed ID: 29031688)
1. Vitamin D deficiency is associated with poor breast cancer prognostic features in postmenopausal women.
de Sousa Almeida-Filho B; De Luca Vespoli H; Pessoa EC; Machado M; Nahas-Neto J; Nahas EAP
J Steroid Biochem Mol Biol; 2017 Nov; 174():284-289. PubMed ID: 29031688
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D deficiency is associated with metabolic syndrome in postmenopausal women.
Schmitt EB; Nahas-Neto J; Bueloni-Dias F; Poloni PF; Orsatti CL; Petri Nahas EA
Maturitas; 2018 Jan; 107():97-102. PubMed ID: 29169589
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of Serum Vitamin D Levels in Egyptian Females with Breast Cancer.
Ismail A; El-Awady R; Mohamed G; Hussein M; Ramadan SS
Asian Pac J Cancer Prev; 2018 Feb; 19(2):571-576. PubMed ID: 29481024
[TBL] [Abstract][Full Text] [Related]
4. Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer.
Park C; Park K; Kim J; Sin Y; Park I; Cho H; Yang K; Bae BN; Kim KW; Ahn S; Gwak G
World J Surg Oncol; 2016 Sep; 14(1):244. PubMed ID: 27619909
[TBL] [Abstract][Full Text] [Related]
5. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
[TBL] [Abstract][Full Text] [Related]
6. Association Between Metabolic Syndrome and Immunohistochemical Profile at Breast Cancer Diagnosis in Postmenopausal Women.
Motoki AH; Buttros DAB; Gaspar AL; Almeida-Filho BS; Carvalho-Pessoa E; Vespoli HDL; Nahas-Neto J; Nahas EAP
Clin Breast Cancer; 2022 Feb; 22(2):e253-e261. PubMed ID: 34465534
[TBL] [Abstract][Full Text] [Related]
7. Low pretreatment serum concentration of vitamin D at breast cancer diagnosis in postmenopausal women.
Machado MRM; de Sousa Almeida-Filho B; De Luca Vespoli H; Schmitt EB; Nahas-Neto J; Nahas EAP
Menopause; 2019 Mar; 26(3):293-299. PubMed ID: 30234730
[TBL] [Abstract][Full Text] [Related]
8. The association between breast cancer prognostic indicators and serum 25-OH vitamin D levels.
Peppone LJ; Rickles AS; Janelsins MC; Insalaco MR; Skinner KA
Ann Surg Oncol; 2012 Aug; 19(8):2590-9. PubMed ID: 22446898
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D deficiency is correlated with poor outcomes in patients with luminal-type breast cancer.
Kim HJ; Lee YM; Ko BS; Lee JW; Yu JH; Son BH; Gong GY; Kim SB; Ahn SH
Ann Surg Oncol; 2011 Jul; 18(7):1830-6. PubMed ID: 21573699
[TBL] [Abstract][Full Text] [Related]
10. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013.
Ehinger A; Malmström P; Bendahl PO; Elston CW; Falck AK; Forsare C; Grabau D; Rydén L; Stål O; Fernö M;
Acta Oncol; 2017 Jan; 56(1):68-74. PubMed ID: 27762648
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer molecular subtypes and receptor status among women at Potchefstroom Hospital: a cross-sectional study.
Kakudji BK; Mwila PK; Burger JR; du Plessis JM; Naidu K
Pan Afr Med J; 2021; 38():85. PubMed ID: 33889251
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of serum 25 hydroxyvitamin D in breast cancer: An Indian scenario.
Patel SR; Patel KD; Patel KR; Gokani RA; Patel JB; Patel PS; Shah FD
J Steroid Biochem Mol Biol; 2020 Sep; 202():105726. PubMed ID: 32682059
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer.
Yamashita H; Ogiya A; Shien T; Horimoto Y; Masuda N; Inao T; Osako T; Takahashi M; Endo Y; Hosoda M; Ishida N; Horii R; Yamazaki K; Miyoshi Y; Yasojima H; Tomioka N;
Breast Cancer; 2016 Nov; 23(6):830-843. PubMed ID: 26467036
[TBL] [Abstract][Full Text] [Related]
14. Discordance of hormone receptor, human epidermal growth factor receptor-2, and Ki-67 between primary breast cancer and synchronous axillary lymph node metastasis.
Kinoe H; Yamanouchi K; Kuba S; Morita M; Sakimura C; Kanetaka K; Takatsuki M; Abe K; Yano H; Matsumoto M; Otsubo R; Hayashida N; Nagayasu T; Eguchi S
J BUON; 2018 Dec; 23(7):60-66. PubMed ID: 30722113
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer in Ethiopia: evidence for geographic difference in the distribution of molecular subtypes in Africa.
Hadgu E; Seifu D; Tigneh W; Bokretsion Y; Bekele A; Abebe M; Sollie T; Merajver SD; Karlsson C; Karlsson MG
BMC Womens Health; 2018 Feb; 18(1):40. PubMed ID: 29444670
[TBL] [Abstract][Full Text] [Related]
16. Association of serum level of 25 hydroxy-vitamin D with prognostic factors for breast cancer.
Kermani IA; Kojidi HT; Gharamaleki JV; Sanaat Z; Ziaei JE; Esfahani A; Seifi S; Ghojazadeh M; Dolatkhah R; Kermani AA; Rad EG
Asian Pac J Cancer Prev; 2011; 12(6):1381-4. PubMed ID: 22126468
[TBL] [Abstract][Full Text] [Related]
17. Ki-67 is a prognostic marker for hormone receptor positive tumors.
Pérez-López ME; García-Gómez J; Alves MT; Paradela A; García-Mata J; García-Caballero T
Clin Transl Oncol; 2016 Oct; 18(10):996-1002. PubMed ID: 26742937
[TBL] [Abstract][Full Text] [Related]
18. The relationship between breast cancer treatment, tumour type and vitamin D level in pre- and postmenopausal women.
Streb J; Glanowska I; Streb A; Szpor J; Kryka K; Potocki P; Wójcik M; Jach R
Neuro Endocrinol Lett; 2017 Dec; 38(6):437-440. PubMed ID: 29298285
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index.
Ono M; Tsuda H; Yoshida M; Shimizu C; Kinoshita T; Tamura K
Clin Breast Cancer; 2017 Feb; 17(1):41-47. PubMed ID: 27477822
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment Serum Concentration of Vitamin D and Breast Cancer Characteristics: A Prospective Observational Mediterranean Study.
Buono G; Giuliano M; De Angelis C; Lauria R; Forestieri V; Pensabene M; Bruzzese D; De Placido S; Arpino G
Clin Breast Cancer; 2017 Nov; 17(7):559-563. PubMed ID: 28601383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]